Clinical trial
Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in…
NCT00204542 · University Hospital Tuebingen, Other · Completed
Key facts
| NCT number | NCT00204542 |
|---|---|
| Title | Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head |
| Official title | Comparison of the Efficacy and Tolerability of Solaraze for 3 vs. 6 Months in Patients With Mild to Moderate Actinic Keratosis Located at the Face and Head |
| Lead sponsor | University Hospital Tuebingen, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Photosensitivity Disorders |
| Intervention type | Drug |
| Interventions | Diclofenac |
| Enrollment | 418 |
| Start date | Jun 1, 2005 |
| Primary completion | Mar 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 19, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: